HC Wainwright & Co. Maintains Buy Rating for TFF Pharmaceuticals: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
HC Wainwright & Co. has maintained its Buy rating for TFF Pharmaceuticals (NASDAQ:TFFP) but lowered its price target from $22.00 to $4.00. TFFP shares are currently trading down 7.08% at $0.55 per share.
May 25, 2023 | 5:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright maintains Buy rating for TFF Pharmaceuticals, lowers price target from $22 to $4. TFFP shares are down 7.08% at $0.55.
HC Wainwright's decision to maintain a Buy rating for TFF Pharmaceuticals indicates a positive outlook for the stock. However, the lowered price target from $22 to $4 suggests a more conservative growth expectation. Despite the current 7.08% drop in share price, the new price target still represents a significant potential increase of 627.27% from the current trading price of $0.55. This news is highly relevant and important for TFFP investors, and the confidence in the analysis is high due to the expertise of HC Wainwright & Co.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100